Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Sales | 127 | 80 | 16,092 | 29,594 | 24,765 |
| Cost of Goods | 49 | N/A | 518 | 1,104 | 840 |
| Gross Profit | 78 | 80 | 15,574 | 28,490 | 23,925 |
| Operating Expenses | 137,393 | 109,657 | 73,825 | 269,422 | 147,350 |
| Operating Income | -137,266 | -109,577 | -57,733 | -240,828 | -122,585 |
| Interest Expense | 10,547 | 33,605 | 17,559 | 10,988 | 9,326 |
| Other Income | 9,627 | 7,363 | -27,213 | -482 | 1,880 |
| Pre-tax Income | -138,186 | -135,819 | -102,505 | -252,298 | -130,031 |
| Net Income Continuous | -138,186 | -135,819 | -102,505 | -252,298 | -130,031 |
| Minority Interests | -78 | N/A | N/A | N/A | N/A |
| Net Income | $-138,108 | $-135,819 | $-102,505 | $-252,298 | $-130,031 |
| EPS Basic Total Ops | -9,823.04 | -14,514.10 | -19,046.19 | -56,028.79 | -46,670.66 |
| EPS Basic Continuous Ops | -9,151.58 | -14,512.84 | -19,051.52 | -56,001.08 | -46,683.22 |
| EPS Diluted Total Ops | -9,823.04 | -14,514.10 | -19,046.19 | -56,028.79 | -46,670.66 |
| EPS Diluted Continuous Ops | -9,151.58 | -14,512.84 | -19,051.52 | -56,001.08 | -46,683.22 |
| EBITDA(a) | $-132,311 | $-103,147 | $-47,455 | $-229,394 | $-114,145 |